Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanism of Dipyridamole Action in Platelets
NCT02226926Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2000
- Primary completion
- Sep 2000
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of dipyridamole in ischemic stroke (3 arms), sponsored by Boehringer Ingelheim. Primary endpoint: VASP-Ser239 / VASP-Ser157-phosphorylation. Started Jul 2000; status: completed.
02
Drugs
dipyridamole
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02226926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02226926.